Altimmune, Inc. (ALT)
3.50
-0.75
(-17.65%)
USD |
NASDAQ |
Mar 05, 16:00
3.64
+0.14
(+4.00%)
After-Hours: 20:00
Altimmune Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Eli Lilly & Co. | -2.802B |
| Viking Therapeutics, Inc. | 75.61M |
| CorMedix, Inc. | -- |
| Actinium Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -66.66M |
| Free Cash Flow Per Share (Quarterly) | -0.133 |
| Free Cash Flow to Equity (Quarterly) | -11.95M |
| Free Cash Flow to Firm (Quarterly) | -11.40M |
| Free Cash Flow Yield | -21.95% |